Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02917759 · ClinicalTrials.gov registry record
Liver and Biliary Tumor Tissue Registry
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 1,000
- Enrollment target
NCT02917759: Clinical Trial study, sponsored by Mayo Clinic.
NCT02917759 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02917759 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Patients having surgery to remove a liver or biliary tissue mass or having a biopsy of a mass or lesion will have a tissue sample collected and stored for future research of liver and biliary diseases. A blood sample may also be collected at the time of enrollment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2014-02 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02917759
The ClinicalTrials.gov registry entry for NCT02917759 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02917759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02917759 about?
NCT02917759 is a clinical study titled "Liver and Biliary Tumor Tissue Registry". Patients having surgery to remove a liver or biliary tissue mass or having a biopsy of a mass or lesion will have a tissue sample collected and stored for future research of liver and biliary diseases. A blood sample may also be collected at the time of enrollment.
What is the current status of trial NCT02917759?
This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 2014-02. Estimated completion is 2025-12.
Who is sponsoring clinical trial NCT02917759?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.